AIMC Topic: Prostatic Neoplasms

Clear Filters Showing 821 to 830 of 1447 articles

Deep Learning Modeling of Androgen Receptor Responses to Prostate Cancer Therapies.

International journal of molecular sciences
Gain-of-function mutations in human androgen receptor (AR) are among the major causes of drug resistance in prostate cancer (PCa). Identifying mutations that cause resistant phenotype is of critical importance for guiding treatment protocols, as well...

Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.

PLoS medicine
BACKGROUND: Prostate cancer (PC) is the most frequently diagnosed cancer in North American men. Pathologists are in critical need of accurate biomarkers to characterize PC, particularly to confirm the presence of intraductal carcinoma of the prostate...

Bone metastasis classification using whole body images from prostate cancer patients based on convolutional neural networks application.

PloS one
Bone metastasis is one of the most frequent diseases in prostate cancer; scintigraphy imaging is particularly important for the clinical diagnosis of bone metastasis. Up to date, minimal research has been conducted regarding the application of machin...

The Silent Operation Theatre Optimisation System (SOTOS) to reduce noise pollution during da Vinci robot-assisted laparoscopic radical prostatectomy.

Journal of robotic surgery
To reduce noise pollution and consequently stress during robot-assisted laparoscopic radical prostatectomy (RALP) the aim of our study was to evaluate the silent operation theatre optimisation system (SOTOS) in its effectiveness. In the operating roo...

Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment.

European radiology
OBJECTIVES: To simulate clinical deployment, evaluate performance, and establish quality assurance of a deep learning algorithm (U-Net) for detection, localization, and segmentation of clinically significant prostate cancer (sPC), ISUP grade group ≥ ...

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
The Gleason score is the most important prognostic marker for prostate cancer patients, but it suffers from significant observer variability. Artificial intelligence (AI) systems based on deep learning can achieve pathologist-level performance at Gle...

Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRI.

AJR. American journal of roentgenology
The purpose of this study was to evaluate in a multicenter dataset the performance of an artificial intelligence (AI) detection system with attention mapping compared with multiparametric MRI (mpMRI) interpretation in the detection of prostate cance...

Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service.

PloS one
OBJECTIVES: The importance of clinical outcome prediction models using artificial intelligence (AI) is being emphasized owing to the increasing necessity of developing a clinical decision support system (CDSS) employing AI. Therefore, in this study, ...

Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy.

BJU international
OBJECTIVES: To develop and validate a risk calculator for prostate cancer (PCa) and clinically significant PCa (csPCa) using explainable artificial intelligence (XAI).

PSA-based machine learning model improves prostate cancer risk stratification in a screening population.

World journal of urology
CONTEXT: The majority of prostate cancer diagnoses are facilitated by testing serum Prostate Specific Antigen (PSA) levels. Despite this, there are limitations to the diagnostic accuracy of PSA. Consideration of patient demographic factors and bioche...